South Africa changes course on vaccine rollout after disappointing study

The government has secured 9 million doses of the Johnson & Johnson vaccine instead, which researchers have said is effective against moderate and severe forms of the coronavirus new variants. They have also secured millions more from the global COVAX and Pfizer.